A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients

ConclusionThe 12-gene prognostic model may serve as a useful complementary clinical risk-stratification tool for stage I and especially stage IA lung squamous cell carcinoma patients to guide clinical decision making.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research